Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Les informations sur les projets et maintenant aussi les résumés de rapports Horizon 2020 sont disponibles sur CORDIS. Tous les projets H2020 peuvent être téléchargés depuis le Portail des données ouvertes de l'UE .

My refinements


Download results of this page


Affiner par:

Advanced search

Rechercher des projets et résultats

Results 1 - 4 of 4
Order by: Results/page:
1
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Date de début: 2018-01-01, Date de fin: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
A global alliance for Zika virus control and prevention
ID: 734548
Date de début: 2016-10-01, Date de fin: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Date de début: 2015-05-01, Date de fin: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.3.
Record Number: 193242
Last updated on: 2017-08-22
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Date de début: 2016-01-01, Date de fin: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
List retrieved on: 2018-09-18